Good Noticings Noticing the Ingredients in David Bars, WNBA Negotiations, and Rebel Wilson
Mar 18, 2026
They dig into a nutrition scandal around a popular protein bar and the ingredient drama behind it. They unpack tense WNBA negotiations and what revenue-share rules mean for the season. They probe a high-profile celebrity legal and PR crisis involving alleged smear tactics. Short takes on FCC media moves and GLP-1 controversies round out the conversation.
AI Snips
Chapters
Books
Transcript
Episode notes
Let Performers Be Nervous At Award Shows
- Stop obsessing over beta blockers and let performers be nervous; the hosts urge empathy for award-show anxiety rather than policing actors' coping methods.
- Claire points to repeated online critiques and says nerves at once-in-a-lifetime events are human and forgiveable.
FCC Shifts From Neutral Regulator To Political Pressure
- The FCC under chairman Brandon Carr is actively reshaping its role from independent regulator to political actor by removing “independent” from its website and threatening broadcasters over Iran coverage.
- Claire Parker and Ashley Hamilton highlight Carr's license-revocation threats and late-night fairness rules as a coordinated multi-pronged attempt to influence media narratives.
GLP-1 Conversation Is Medical Concern And Moral Theater
- Public discourse around GLP-1 drugs (Ozempic) mixes valid medical concern with performative moralizing, producing polarized outrage rather than clear policy debate.
- Hosts use Brianna Chickenfry's comments and Layla Taylor's admission of GLP-1 abuse to show overprescription and eating-disorder risk amid influencer drama.
